Rabies Clinical Trials 2023

What are the top hospitals conducting rabies research?

In the realm of clinical trials for rabies, there is one hospital that stands out as a beacon of hope and innovation. The Emory Vaccine Center - The Hope Clinic in Decatur has taken on the challenge of combating this deadly viral disease with their dedicated efforts. While they currently have only one active trial focused on rabies, it represents a crucial step towards finding better treatments and prevention methods. This trial marks their first recorded endeavor in tackling rabies, having commenced just recently in 2019.

Rabies is a highly infectious disease transmitted through bites or scratches from infected animals, primarily dogs, bats, and raccoons. It affects the nervous system and can be fatal if not promptly treated. Despite being preventable through vaccination protocols for both humans and animals, around 59,000 people die from rabies each year worldwide.

The location of Emory Vaccine Center - The Hope Clinic adds an interesting dimension to their work against rabies. Located in Decatur, Georgia—a suburb of Atlanta—the center benefits from its proximity to the renowned research powerhouse at Emory University School of Medicine as well as other leading healthcare institutions within the area. Together with scientific collaborations and state-of-the-art facilities at their disposal, researchers at this clinic are working tirelessly to advance our understanding of rabies while striving to develop effective strategies for its control.

Every small stride made by hospitals like Emory Vaccine Center - The Hope Clinic brings us closer to conquering this ancient scourge that has plagued humanity for centuries. Through rigorous clinical trials such as those conducted here, we gain valuable insights into potential breakthroughs that may ultimately save countless lives threatened by this devastating disease.

Which are the best cities for rabies clinical trials?

Decatur, Georgia emerges as the leading city for rabies clinical trials. With one active trial currently underway, researchers in Decatur are studying ChAd155-RG and other potential treatments. This concentrated focus on advancing our understanding and treatment of rabies makes Decatur a standout location for individuals seeking opportunities to participate in cutting-edge clinical trials.

Which are the top treatments for rabies being explored in clinical trials?

In the realm of rabies treatment, ChAd155-RG stands at the forefront. This innovative therapy is currently being explored in one active clinical trial dedicated to fighting this deadly disease. Since its introduction in 2019, it has marked a significant milestone as the sole intervention studied specifically for rabies, with no other trials conducted thus far. With promising potential and ongoing research efforts, ChAd155-RG offers hope for advancements in treating this devastating condition.

What are the most recent clinical trials for rabies?

Significant progress is being made in the field of rabies research, bringing hope to those affected by this deadly disease. One recent clinical trial focused on ChAd155-RG, a potential vaccine candidate for rabies. The trial, conducted during Phase 1, commenced on 9/19/2019. Although further studies are needed to fully evaluate its efficacy and safety profile, this development marks an important step forward in combatting rabies and protecting individuals from its devastating consequences.

What rabies clinical trials were recently completed?

Recently completed clinical trials for rabies have made notable strides in the fight against this deadly disease. In September 2019, Synermore Biologics Co., Ltd. successfully concluded a trial evaluating the effectiveness of SYN023 as a potential treatment option. Additionally, GlaxoSmithKline wrapped up their trial investigating a lower dose formulation of RG SAM (CNE) vaccine (GSK3903133A) in August 2019. These significant advancements bring hope to the field of rabies research and offer promising prospects for improved prevention and management strategies moving forward.